Pfizer continues to support ACTI-MENU with annual Challenge

KIRKLAND, QC, April 29 /CNW/ - As a program partner, Pfizer Canada congratulates ACTI-MENU on the success of the twelfth annual Quit to Win! Challenge in support of a smoke-free Quebec following this morning's closing ceremonies.

This year, more than 23,000 participants engaged in the Challenge; accounting for an almost 50 per cent increase from last year. To meet the needs of smokers wanting to quit, this year's Challenge was more flexible than in previous years. Each participant was given the opportunity to put together a personalized Challenge and thus maximize his or her chances of success. This included registration, either alone, or with a sponsor, and access to a variety of free support tools.

"Pfizer is proud to be a partner with ACTI-MENU in the Quit to Win! Challenge which provided help and support to the many smokers in Quebec who struggle to quit smoking and deal with their nicotine addiction," said Paul Lévesque, President Pfizer Canada. "It is the addiction aspect of smoking that is the reason why only a small percentage of smokers are able to quit without assistance and why it is important that motivated quitters also involve a healthcare professional.  As a healthcare partner we believe that we can - or more precisely - we must - work together with other innovative healthcare partners to improve the health of the province by supporting people in quitting smoking."

About the Quit to Win! Challenge
The Quit to Win! Challenge is an ACTI-MENU initiative developed in partnership with several public and private organizations, including the ministère de la Santé et des Services sociaux du Québec, Quebec's departments of public health, the Canadian Cancer Society, Jean Coutu, Pfizer, Novartis, and TELUS Health Solutions.

These partners have contributed to the Challenge's broad visibility and renown. Many individuals from the health network and various professional associations were also called upon to help promote the Challenge and its alliance with provincial smoking cessation services, and to ensure its deployment throughout Quebec.

ACTI-MENU is a social enterprise wholly owned by three foundations: Fondation Prévention Santé Intégrale, Fondation ÉPIC, and Fondation de l'Hôpital Maisonneuve-Rosemont. ACTI-MENU develops its programs and services in partnership with such prestigious institutions as the Montreal Heart Institute and Hôpital Maisonneuve-Rosemont.

About Pfizer Canada
Pfizer Canada Inc. is the Canadian operation of Pfizer Inc, the world's leading biopharmaceutical company. The company is one of the largest contributors to health research in Canada. Our diversified health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as many of the world's best-known consumer products.

Every day, Pfizer Canada employees work to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We apply science and our global resources to improve the health and well-being of Canadians at every stage of life.

Our commitment is reflected in everything we do, from our disease awareness initiatives to our community partnerships, to our belief that it takes more than medication to be truly healthy. To learn more about Pfizer's More Than Medication philosophy and programs, visit To learn more about Pfizer Canada, visit

More Than Medication™ is a registered trademark of Pfizer Canada Inc.


For further information:

Heather Bisset
Manager, Corporate Communications
Pfizer Canada
1-866-9(PFIZER) 973-4937

Profil de l'entreprise


Renseignements sur cet organisme


Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .


Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.


Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.